These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 21106770

  • 1. Beneficial effects of C-peptide on renal morphology in diabetic rats.
    Sun W, Gao X, Zhao X, Cui D, Xia Q.
    Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):893-9. PubMed ID: 21106770
    [Abstract] [Full Text] [Related]

  • 2. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

  • 3. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide.
    Yuan P, Xue H, Zhou L, Qu L, Li C, Wang Z, Ni J, Yu C, Yao T, Huang Y, Wang R, Lu L.
    Nephrol Dial Transplant; 2011 Jul 20; 26(7):2119-26. PubMed ID: 21208996
    [Abstract] [Full Text] [Related]

  • 4. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
    Samnegård B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B, Eriksson L, Wahren J, Sjöquist M.
    Nephrol Dial Transplant; 2005 Mar 20; 20(3):532-8. PubMed ID: 15665028
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases.
    McLennan SV, Kelly DJ, Cox AJ, Cao Z, Lyons JG, Yue DK, Gilbert RE.
    Diabetologia; 2002 Feb 20; 45(2):268-75. PubMed ID: 11935159
    [Abstract] [Full Text] [Related]

  • 7. Proteomic profile of primary isolated rat mesangial cells in high-glucose culture condition and decreased expression of PSMA6 in renal cortex of diabetic rats.
    Li Z, Zhang H, Dong X, Burczynski FJ, Choy P, Yang F, Liu H, Li P, Gong Y.
    Biochem Cell Biol; 2010 Aug 20; 88(4):635-48. PubMed ID: 20651835
    [Abstract] [Full Text] [Related]

  • 8. Influence of C-peptide on early glomerular changes in diabetic mice.
    Maezawa Y, Yokote K, Sonezaki K, Fujimoto M, Kobayashi K, Kawamura H, Tokuyama T, Takemoto M, Ueda S, Kuwaki T, Mori S, Wahren J, Saito Y.
    Diabetes Metab Res Rev; 2006 Aug 20; 22(4):313-22. PubMed ID: 16389646
    [Abstract] [Full Text] [Related]

  • 9. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, Kim YS, Cha DR.
    Nephrol Dial Transplant; 2006 Sep 20; 21(9):2406-16. PubMed ID: 16728425
    [Abstract] [Full Text] [Related]

  • 10. Delivery of megsin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by down-regulating p27(kip1) level.
    Liu M, Zhang Y, Chi Y, Zhai S, Wang B, Shi Y, Li Y.
    J Nephrol; 2012 Sep 20; 25(3):418-25. PubMed ID: 21928229
    [Abstract] [Full Text] [Related]

  • 11. Effects of pioglitazone on expressions of matrix metalloproteinases 2 and 9 in kidneys of diabetic rats.
    Dong FQ, Li H, Cai WM, Tao J, Li Q, Ruan Y, Zheng FP, Zhang Z.
    Chin Med J (Engl); 2004 Jul 20; 117(7):1040-4. PubMed ID: 15265379
    [Abstract] [Full Text] [Related]

  • 12. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
    Zuo Y, Gu Y, Ma J, Lin S.
    Zhonghua Yi Xue Za Zhi; 2002 Feb 25; 82(4):239-43. PubMed ID: 11953170
    [Abstract] [Full Text] [Related]

  • 13. Proinsulin C-peptide prevents type-1 diabetes-induced decrease of renal Na+-K+-ATPase alpha1-subunit in rats.
    Nordquist L, Shimada K, Ishii T, Furuya DT, Kamikawa A, Kimura K.
    Diabetes Metab Res Rev; 2010 Mar 25; 26(3):193-9. PubMed ID: 20225182
    [Abstract] [Full Text] [Related]

  • 14. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
    Kenichi M, Masanobu M, Takehiko K, Shoko T, Akira F, Katsushige A, Takashi H, Yoshiyuki O, Shigeru K.
    J Lab Clin Med; 2004 Aug 25; 144(2):69-77. PubMed ID: 15322501
    [Abstract] [Full Text] [Related]

  • 15. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion.
    Tomita M, Koike H, Han GD, Shimizu F, Kawachi H.
    Clin Exp Nephrol; 2004 Mar 25; 8(1):17-26. PubMed ID: 15067512
    [Abstract] [Full Text] [Related]

  • 16. Glibenclamide prevents increased extracellular matrix formation induced by high glucose concentration in mesangial cells.
    Giannico G, Cortes P, Baccora MH, Hassett C, Taube DW, Yee J.
    Am J Physiol Renal Physiol; 2007 Jan 25; 292(1):F57-65. PubMed ID: 16896180
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
    Akahori H, Ota T, Torita M, Ando H, Kaneko S, Takamura T.
    J Pharmacol Exp Ther; 2005 Aug 25; 314(2):514-21. PubMed ID: 15857946
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
    Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM.
    Diabetes; 2008 Feb 25; 57(2):460-9. PubMed ID: 17959934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.